Neuphoria Therapeutics Inc (NEUP) financials · rev $1.2M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Neuphoria Therapeutics Inc (NEUP) rev $1.2M.
| Line | FY2026 | FY2025 |
|---|---|---|
| Revenue | $1.17M | $15.6M |
| Operating Income | -$16.5M | -$1.13M |
| Net Income | -$13.5M | -$369.6K |
| EPS (Diluted) | N/A | N/A |
| Line | FY2026 | FY2025 |
|---|---|---|
| Total Assets | $28.7M | $28.6M |
| Current Assets | $21.1M | $15.0M |
| Cash & Equivalents | $19.9M | $14.2M |
| PP&E | N/A | $2.77K |
| Total Liabilities | $4.11M | $9.59M |
| Current Liabilities | $756.6K | $4.22M |
| Shareholders' Equity | $24.6M | $19.0M |
| Retained Earnings | -$191.8M | -$178.3M |
| Line | FY2026 | FY2025 |
|---|---|---|
| Operating Cash Flow | -$12.4M | $77.2K |
| Financing Cash Flow | $17.9M | $1.53M |
| Net Change in Cash | $5.58M | $1.60M |
FAQ
What is NEUP P/E and revenue?
Neuphoria Therapeutics Inc (NEUP) rev $1.2M.
What is NEUP revenue?
Neuphoria Therapeutics Inc last cached revenue is $1.17M (FY2026).
Is NEUP profitable?
Neuphoria Therapeutics Inc last cached net income is -$13.5M (FY2026).
What are NEUP total assets?
Neuphoria Therapeutics Inc last cached total assets are $28.7M (FY2026).
What is NEUP free cash flow?
No cached cash-flow row for NEUP yet.
Not investment advice. Cached statements, not a live tape.